Due to the key roles of APP in the pathogenesis of AD, APP overexpression has been widely applied in the establishment of AD models in vivo (Webster et al., 2014; Gao et al., 2019) and in vitro (Atluri et al., 2019; Lin et al., 2019). This evidence concerns the gene APP and Alzheimer disease.